Courses & Workshops Opportunities Patent

Virtual Workshop for Students on ‘Nuances of Patent Processing’ [October 26-28, 2020]


We’re pleased to inform you that DPIIT IPR Chair at Maharashtra National Law University (MNLU), Nagpur is organising a three day free virtual workshop for students on ‘Nuances of Patent Processing’ from October 26-28, 2020. For further details, please read the announcement below. Three-day Virtual Workshop on ‘Nuances of Patent Processing’ by DPIIT IPR CHAIR at Maharashtra National Law University, Nagpur | October 26-28, 2020 The Chair for Intellectual Property Rights of Maharashtra National Law University, Nagpur proposes three-day virtual…


Read More »
Copyright

Is Copyright a Hindrance for Open Access in India?


On the occasion of International Open Access Week, we’re delighted to bring to our readers an insightful post by Dr. Arul George Scaria, discussing whether the process of relinquishment of rights granted to authors under the Indian copyright law may cause copyright to be a hindrance for open access in India. Dr. Scaria is an Associate Professor of Law and Co-Director of the Centre for Innovation, Intellectual Property and Competition (CIIPC) at National Law University, Delhi. He did his doctoral…


Read More »
Opportunities Publication

Call for Papers: NUALS’ Book on Sustainability and Intellectual Property Law [Submit by December 30]


We’re pleased to inform you that the Centre for Intellectual Property Rights at National University of Advanced Legal Studies (NUALS), Kochi is seeking papers for its book on the theme: ‘Innovate for a Green Future: Role of IP Rights in Encouraging Innovation and Creativity’. The last date for the submissions is November 15, 2020. [Edit: The deadline has been extended to December 30, 2020.]   Call for Papers: NUALS’ Book on Sustainability and Intellectual Property Law  The Centre for Intellectual…


Read More »
Patent

Nivolumab and 5C4 – Big Brother or Twin brothers?


As there is a lot of text here, please reach out to swaraj@spicyip.com for an accessible copy of the flowchart

We’re pleased to bring our readers an in-depth post looking at the grant of a patent application related to the anti-cancer drug Nivolumab, written by Dr. Venkata Subramanian Raman and Ms Sai Ratna Manjari. Dr. Venkata Subramanian Raman is a registered patent agent and proprietor of Patentszone, and Ms. Sai Ratna Manjari is a registered patent agent providing IPR consulting service and also associated with Patentszone. (Please note that given the nature of examination in the current post, it is…


Read More »
Trademark

Delhi HC Delivers a Blow to “Delhivery”: Rules the Mark to be Phonetically Generic; Ineligible for Statutory Benefits


In an interesting turn of events, the Delhi HC on 12th October, 2020, vacated an interim injunction effectively permitting the Respondent (Treasure Vase Ventures Pvt. Ltd.) to use the impugned trademark ‘DELIVER-E’.  In doing so the court held that the Applicant’s (Delhivery Pvt. Ltd.) registered trademark ‘DELHIVERY’ is phonetically similar to the English word ‘delivery’ and is a generic mark, not eligible for benefit of statutory rights. The court reiterated that unless a generic mark has achieved distinctiveness, it cannot…


Read More »
Patent

China Enters the Realm of Anti-Suit Injunctions in Standard Essential Patent (SEP) Cases


We’re pleased to bring to you a guest post by Dr. Enrico Bonadio (City, University of London – Fellow of the Innovators Network Foundation during 2019-2020), Dr. Luke McDonagh (London School of Economics – Fellow of the Innovators Network Foundation during 2019-2020) and Dr. Plamen Dinev (Goldsmiths, University of London), commenting on the recent Chinese decisions granting anti-suit injunctions in two SEP cases, one of which was discussed on the blog earlier this month here. China Enters the Realm of…


Read More »
Copyright COVID-19 Patent Trade Secret

Wishful Thinking? Analyzing India and South Africa’s Joint Statement to Waive Key Provisions of TRIPS- Part II


In the first part of this two-part post, I assessed the joint statement proposed by South Africa and India for waiver of certain key provisions of TRIPS. Following the joint statement, 379 NGOs and members of civil societies wrote to WTO, in support of the waiver. On the day of the meeting, the proposal attracted the support of a large number of developing countries and LDCs, notably Tanzania, Chad, Bangladesh, Sri Lanka, Pakistan, Venezuela, Honduras, Nepal, Nicaragua, Egypt, Indonesia, Argentina,…


Read More »
Copyright COVID-19 Overlaps in IP Patent Trade Secret

Wishful Thinking? Analyzing India and South Africa’s Joint Statement to Waive Key Provisions of TRIPS – Part I


On 2nd October, 2020, India and South Africa issued a joint statement before the WTO TRIPS Council, with a request to waive “the implementation, application and enforcement of Sections 1, 4, 5, and 7 of Part II of the TRIPS Agreement in relation to prevention, containment or treatment of COVID-19.” This waiver, annexed with a draft decision for the WTO General Council, was requested to ensure that IPRs do not encumber the access to affordable medicines or R&D, manufacturing and…


Read More »
Patent

Only ‘Disclosed’ if ‘Identified’: IPAB Quashes Ceritinib Patent Revocation


An IPAB bench consisting of Chairman Manmohan Singh J. and the new technical member for Patents Dr. B.P. Singh has quashed the Controller of Patent’s decision that revoked Novartis’s patent on the anti-cancer drug Ceritinib. It held that while the compound was contained in a broader genus patent, it was not ‘disclosed’ therein, as it hadn’t been specifically identified. The 104-page order examines several issues regarding novelty and obviousness, the extent of coverage and disclosure, and timelines for filing of…


Read More »
Copyright Patent Trademark

SpicyIP Weekly Review (October 12 – 18)


Topical Highlight Delhi High Court Issues Anti Anti-Suit Injunction in InterDigital v. Xiaomi Patent Infringement Dispute In a guest post, Rajiv looks at the anti anti-suit injunction granted by the Delhi High Court (‘DHC’) against Xiaomi in the patent infringement dispute with InterDigital. He highlights that the court viewed the lis as not impacting the proceedings before the Wuhan Court concerning fixation of FRAND rates. He considers that Xiaomi should have pursued a different strategy than the one it adopted….


Read More »